https://orcid.org/0000-0003-1531-9682
References
- Das A, Martinez Santos JL, Alshareef M, Porto GBF, Infinger LK, Vandergrift WA, et al. In vitro effect of dovitinib (TKI258), a multi-target angiokinase inhibitor on aggressive meningioma cells. Cancer Invest. 2020;38(6):349–355. doi:10.1080/07357907.2020.1773844.
- Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, et al. Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc Natl Acad Sci USA. 2019;116(43):21715–21726. doi:10.1073/pnas.1912858116.
- Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. doi:10.1038/ncomms3612.